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Objective: Our objective is to determine whether gender is a marker or a causal
influence for poor outcomes after coronary revascularization.
Methods: Propensity-modeling techniques were used to investigate whether gender
adversely impacts outcomes after coronary revascularization. A parsimonious ex-
planatory model was developed by bootstrap bagging with variable selection from
64 baseline and 37 operative variables. Propensity scores were calculated from a
logistic model that included the parsimonious model and additional baseline vari-
ables. Greedy matching techniques were applied to match female and male patients
to the nearest propensity scores. Comparisons were made among the propensity-
matched women and men.
Results: Of the 15,597 patients undergoing isolated coronary artery bypass graft
surgery, only 26% of the 3596 women were matched on propensity scores with men.
Distribution of covariates among the matched pairs was, on average, equal. Post-
operative mortality (P  .76), neurologic morbidity (global deficit P  .07, focal
deficit P  .51), infection (sepsis P  .88), mediastinitis (P  .18), renal failure (P
 .84), intra-aortic balloon pump usage (P  .61), and reoperation for bleeding (P
 .10) were similar among women and men. Occurrence of Q-wave myocardial
infarction (P   .01), postoperative inotropic usage (P   .01), and prolonged
ventilatory support (P  .02) were more common in women compared with
propensity-matched men.
Conclusions: The preoperative profiles of women and men are markedly different.
Propensity matching women and men was difficult, because only 26% of women
were able to be matched with men. However, in well-matched patients, female
gender was not associated with increased mortality and had minimal impact on
morbidity after coronary artery bypass grafting.
Risk of morbidity and mortality after coronary artery bypass grafting(CABG) is reported to be higher for women than for men.1-8However, studies examining an independent effect of gender onoutcomes after CABG have produced variable results.1-15 Ourobjective was to determine whether gender is merely a marker fora high-risk profile or whether it has a causal influence on increased
postoperative morbidity and mortality after CABG. This was investigated by ap-
plying propensity-modeling techniques to a large database of isolated patients who
underwent CABG.
Methods
Patient Population
From January to June 2002, 15,597 patients underwent isolated CABG surgery at the
Cleveland Clinic Foundation. All data were prospectively collected and entered into the
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computer database by trained database management personnel.
Institutional review board approval was obtained from The Cleve-
land Clinic Foundation to perform research analyses on the insti-
tution’s databases,
Statistical Methods
Data for 64 baseline and 37 operative and postoperative variables
were collected. The aim of the analysis was to match female and
male patients according to baseline characteristics and compare
surgical outcomes between the matched groups.
Before matching patients, a parsimonious explanatory model
was developed by bootstrap bagging for variable selection.16 Base-
line variables found to be significantly associated with gender were
identified.17 A propensity score, in logit units, was then obtained
by calculating the predicted value for each observation from a
logistic model including the variables identified in the parsimoni-
ous model plus additional baseline variables, for a total of 68
covariates. These scores represent a summary of baseline charac-
teristic for each observation. Greedy matching techniques were
then used to select male counterparts to the female patients by
choosing the patient with the nearest propensity score.18 This
resulted in 945 matches (26% of the women and 8% of the men).
Univariable comparisons were made among the matched and un-
matched groups using the Student t and Wilcoxon rank tests for
continuous variables and the chi-square and Fisher’s exact tests for
categoric variables.
Propensity Score Justification
Associations found through traditional multivariable regression
may be misleading because of underrepresentation of 1 covariate
of interest within levels of another. Thus, subclassification with
propensity scores is used to adjust for confounding background
characteristics.19 To illustrate the advantage of using propensity
scores, a logistic model was developed for hospital mortality using
the entire original data set irrespective of matching. A parsimoni-
ous model was constructed by bagging (bootstrap aggregation)
with 200 samples to identify significant covariates in the model. A
cluster analysis was then used to identify correlations among them.
Variables significant in at least 50% of the samples were placed
into the model. The significance of gender was then assessed by
first forcing in an indicator variable for female, followed by adding
a covariate for the propensity score.
Propensity Matching Coronary Reoperations
Coronary revascularization procedures pose an increased risk for
both postoperative morbidity and mortality. We investigated
whether there were gender differences in this subset of patients
with the application of propensity-matching techniques. Of the
patients who underwent coronary reoperation, 176 women (36%)
and 149 men (5%) were propensity matched. By using the Student
Figure 1. Mirrored histogram distribution of propensity scores for
women and men, reflective of their preoperative profiles, are
dissimilar. Note there is minimal overlap in distribution of pro-
pensity scores among the women and men.
TABLE 1. Baseline continuous variables between matched pairs
Characteristic
Matched females Matched males Student t test
N Mean  SD N Mean  SD P value
Demographics
Age at surgery (yr) 945 65.6 10.2 945 65.9 10.4 .54
Height (cm) 945 164.4 6.8 945 164.7 11.1 .50
Weight (kg) 945 78.4 16.2 945 77.4 14.9 .18
Body mass index (kg/m2) 945 29.1 6.0 945 29.0 8.4 .86
Body surface area (m2) 945 1.8 0.2 945 1.8 0.2 .45
Preoperative laboratory values
Hematocrit (%) 945 39.5 4.1 945 36.1 5.1 .01
Bilirubin (mg/dL) 867 0.6 0.4 872 0.6 0.3 .99
Albumin (g/dL) 866 3.9 0.5 871 3.9 0.6 .20
BUN (mg/dL) 945 19.7 10.2 945 19.9 10.8 .61
Serum creatinine (mg/dL) 945 1.2 1.0 945 1.2 1.0 .41
Triglycerides (mg/dL) 450 201.6 183.9 454 201.4 193.5 .98
HDL cholesterol (mg/dL) 453 41.9 12.4 454 42.0 13.4 .85
LDL cholesterol (mg/dL) 442 128.4 43.8 448 125.8 46.0 .40
Red cell mass estimate (L) 945 1.7 0.3 945 1.7 0.3 .24
HDL, High-density lipoprotein; LDL, low-density lipoprotein; BUN, blood urea nitrogen.
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t and Wilcoxon rank tests for continuous variables and the chi-
square and Fisher’s exact tests for categoric variables, comparisons
were made among the propensity-matched patients who underwent
reoperative CABG.
Results
Matching
Of 3596 female patients undergoing CABG, 945 (26%)
could be matched with men. This reflects the vast gender
difference in preoperative profiles resulting in little overlap
in baseline characteristics among women and men (Figure
1). Baseline characteristics among the propensity-matched
groups are listed in Tables 1 and 2. The distribution of age,
height, weight, body surface area (BSA), body mass index
(BMI), preoperative laboratory values of albumin, bilirubin,
blood urea nitrogen, serum creatinine, triglycerides, high-
and low-density lipoprotein cholesterol, and red cell mass
TABLE 2. Baseline categoric variables between matched pairs
Characteristic
Female Male Chi-square test
P valueN % N %
Preoperative medication
ACE inhibitors 249 26 252 27 .88
Antiarrhythmics 119 13 119 13 .99
Beta blockers 534 57 542 57 .71
Calcium channel blockers 335 36 321 34 .50
Statins 26 2.8 16 1.7 .12
Clinical history
Myocardial infarction 524 56 530 56 .78
Chronic obstructive pulmonary disease 84 8.9 85 9.0 .94
Smoking 566 60 560 59 .78
Heart failure 206 22 219 23 .47
Hypertension 696 74 690 73 .76
Diabetes: insulin treated 170 18 168 18 .90
Diabetes: non-insulin treated 177 19 186 20 .60
Stroke 76 8.0 75 7.9 .93
Peripheral vascular disease 154 16 153 16 .95
Renal disease 23 2.4 11 1.2 .04
Alcohol use 42 4.4 38 4.0 .65
Atrial fibrillation 42 4.4 46 4.9 .66
Unstable angina 366 39 366 39 .99
Preoperative pathology
Aortic valve regurgitation 52 5.5 63 6.7 .29
Aortic valve stenosis 11 1.2 15 1.6 .43
Mitral valve regurgitation 159 17 176 19 .31
Coronary artery disease
Any circumflex system disease 799 85 797 85 .94
Any left main disease 376 40 371 40 .81
Any LAD system disease 897 95 892 95 .67
Any RCA system disease 838 89 836 89 .94
Symptoms
NYHA class .88
1 116 13 125 14
2 374 42 366 42
3 135 15 126 14
4 260 29 259 30
Canadian angina class .93
0 25 2.8 25 2.9
1 280 32 266 30
2 422 48 419 48
3 135 15 138 16
4 23 2.6 28 3.2
Emergency surgery 37 3.9 37 3.9 .99
Cardiogenic shock 5 0.53 5 0.53 .99
Intra-aortic balloon pump 923 98 913 97 .17
Ventricular function
Abnormal left ventricular function 475 50 493 52 .41
ACE, Angiotension-converting enzyme; LAD, left anterior descending; RCA, right coronary artery; NYHA, New York Heart Association.
Surgery for Acquired Cardiovascular Disease Koch et al
2034 The Journal of Thoracic and Cardiovascular Surgery ● December 2003
A
CD
estimates were similar among the matched pairs.
Preoperative medication usage, comorbidities such
as hypertension and diabetes, and history of stroke
and unstable angina were also equally distributed. There
were similarities in the distribution for the extent
of coronary artery disease, abnormal left ventricular
function, New York Heart Association functional classi-
fication, or Canadian angina class among the matched
pairs. There was a slightly higher prevalence of preop-
erative renal disease and higher hematocrits in the
propensity-matched women compared with the similarly
matched men.
TABLE 3. Outcome variables between matched pairs
Matched females (N  945) Matched males (N  945)
Continuous variables Median (25th, 75th percentile) Median (25th, 75th percentile) Wilcoxon rank
P value
Total minutes myocardial ischemia 63 (44, 81) 67 (49, 84) .01
Total no. of units of RBC in OR and ICU 2.0 (0.0, 3.0) 2.0 (0.0, 3.0) .05
Hours on ventilator in ICU 12 (7.5, 18) 11 (7.3, 17) .02
Hematocrit in ICU 31 (28, 33) 30 (28, 33) .01
Categoric variables
Matched females Matched males Chi-square test
P valueN % N %
Coronary endarterectomy 11 1.2 13 1.4 .68
Hospital death 20 2.1 22 2.3 .76
Complications
Neurologic morbidity
Encephalopathy 12 1.3 7 7.4 .25
Focal deficit 12 1.3 9 .95 .51
Global deficit 7 0.74 1 0.11 .07F
Pulmonary morbidity
ARDS 4 0.42 6 0.63 .53
Aspiration pneumonia 1 0.11 7 0.74 .07F
Pneumonia 18 1.9 26 2.8 .22
Pulmonary edema 10 1.1 13 1.4 .53
Tracheostomy 15 1.6 20 2.1 .39
Pulmonary embolus 2 0.21 0 0.0 .50F
Plural effusion 206 22 167 18 .02
Renal morbidity
Renal failure 13 1.4 12 1.3 .84
Anuria 12 1.3 4 0.42 .05
Renal protective dopamine 167 18 194 21 .11
Infection
Sternal wound infection 2 0.21 3 0.32 .99F
Mediastinitis 2 0.21 7 0.74 .18F
Septicemia/sepsis 22 2.3 23 2.4 .88
Endocarditis 0 0.0 1 0.11 .99F
Cardiac morbidity
Low cardiac output 15 1.6 13 1.4 .7
Cardiac arrest 56 5.9 34 3.6 .02
Atrial fibrillation 137 15 128 14 .55
Myocardial infarction 115 12 71 7.5 .01
Intra/Postoperative IABP 49 5.2 54 5.7 .61
Antiarrythmics 133 14 148 16 .33
Inotropic agents 339 36 248 26 .01
Vasopressors 3 0.32 1 0.11 .62F
Multisystem organ failure 7 0.74 5 0.53 .56
Blood product usage
Intra/postoperative red blood cells 655 69 595 63 .01
Cryoprecipitate or platelets given 110 12 112 12 .89
Reoperation for bleeding/tamponade 18 1.9 29 3.1 .1
OR, Operating room; F, Fisher’s exact test; ICU, intensive care unit; ARDS, acute respiratory distress syndrome; IABP, intra-aortic balloon pump; RBC, red
blood cell.
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Outcomes Comparison
Postoperative morbidity and mortality outcomes among the
propensity-matched pairs are displayed in Table 3. The
occurrence of postoperative mortality, neurologic morbid-
ity, infection, arrhythmias, renal failure, intra-aortic balloon
pump (IABP) usage, and reoperation for bleeding and tam-
ponade were similar between the propensity-matched pairs.
However, women had shorter myocardial ischemic time,
received more intraoperative and intensive care unit (ICU)
red blood cell transfusions, required longer postoperative
ventilatory support in the ICU, and had more postoperative
myocardial infarctions, cardiac arrests, and pleural effu-
sions. Women also required greater use of inotropic support
in the postoperative period.
Unmatched Women
The unmatched women represented a distinct group com-
pared with the matched women and men (Tables 4 and 5).
The distribution of propensity scores among the women
who were propensity matched with men and the women
(74%) who were unable to be matched on propensity scores
with men is displayed in Figure 2. Unmatched women were
older and shorter, weighed less, and had a smaller BSA and
BMI. The unmatched women had lower preoperative hema-
tocrits, bilirubin, albumin, serum creatinine, and estimates
of red blood cell mass. Their triglyceride and low-density
lipoprotein cholesterol values were also less favorable. The
unmatched women smoked cigarettes and drank alcohol less
frequently, had less preoperative renal disease, and had a
higher prevalence of preoperative IABP usage than the
matched women.
Unadjusted comparisons of mortality and morbidity out-
comes for the matched and unmatched women were similar
with respect to in-hospital mortality, postoperative neuro-
logic and pulmonary morbidity, renal failure, inotropic us-
age, and reoperation for bleeding and tamponade. The un-
matched women received more intraoperative and ICU red
blood cell transfusions than matched women (Table 6).
Total Population of Women and Men
Unadjusted comparisons. Unadjusted postoperative
morbidity and mortality outcomes among the 3596 women
and 12,001 men are presented in Table 7. Women not only
had a higher postoperative mortality compared with men
(women 2.4% vs men 1.4%) but also had a greater occur-
rence of all major postoperative morbidities, such as neu-
rologic, pulmonary, renal, and cardiac morbidities, postop-
erative septicemia, multisystem organ failure, and use of red
blood cell products.
Multivariable logistic regression for postoperative mor-
tality. The factors independently associated with postoper-
ative mortality in the multivariable logistic model are pre-
sented in Table 8. Advanced age, history of peripheral
vascular disease and heart failure, previous bypass graft
disease, major perioperative blood transfusion, and abnor-
mal left ventricular function were all associated with in-
hospital mortality. Less hyperlipidemia, ramus stenosis, and
albumin were associated with a lower probability of in-
hospital death. After accounting for these factors, female
gender was statistically significant (P  .04) but unreliable
(6% probability that P  .05 in the bootstrap aggregation).
After further adjustments for propensity score, its P value
became .1695. There was no significant interaction between
age and gender in the multivariable model (P  .5).
Reoperative Coronary Artery Bypass Grafting
Postoperative morbidity and mortality outcomes among the
propensity-matched women and men who underwent coro-
TABLE 4. Baseline continuous variables between unmatched and matched females
Characteristic
Unmatched females Matched females Student t test
P valueN Mean  SD N Mean  SD
Demographics
Age at surgery (yr) 2645 67 10 945 66 10 .01
Height (cm) 2645 157 7.0 945 164 6.8 .01
Weight (kg) 2645 71 15 945 78 16 .01
Body mass index (kg/m2) 2645 29 6.5 945 29 6.0 .51
Body surface area (m2) 2645 1.7 0.2 945 1.8 0.2 .01
Preoperative laboratory values
Hematocrit (%) 2645 36 4.1 945 40 4.1 .01
Bilirubin (mg/dL) 2430 0.5 0.3 867 0.6 0.4 .01
Albumin (g/dL) 2431 3.9 0.5 866 3.9 0.5 .01
BUN (mg/dL) 2645 19 11 945 20 10 .07
Serum creatinine (mg/dL) 2645 1.0 0.6 945 1.2 1.0 .01
Triglycerides (mg/dL) 1299 203 162 450 202 184 .89
HDL cholesterol (mg/dL) 1291 46 14 453 42 12 .01
LDL cholesterol (mg/dL) 1274 133 49 442 128 44 .07
Red cell mass estimate (L) 2645 1.4 0.3 945 1.7 0.3 .01
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nary reoperations are presented in Table 9. Women had a
lower postoperative mortality compared with similarly
matched men (women 2.3% vs men 6.7%). The occur-
rence of major postoperative morbidities were similar
among the propensity-matched groups except for a
greater use of antiarrhythmics in men (women 11% vs
men 23%).
Discussion
Nature of the Debate
Many studies examining gender differences outcomes after
CABG report a higher unadjusted postoperative morbidity
and mortality for women compared with men.1-9 The debate
has centered on whether gender differences in outcome are
attributable to female gender per se or to a higher preva-
TABLE 5. Baseline categoric variables between unmatched and matched females
Characteristic
Unmatched females Matched females Chi-square test
P valueN % N %
Preoperative medication
ACE inhibitors 772 29 249 26 .10
Antiarrhythmics 343 13 119 13 .77
Beta blockers 1553 59 534 57 .24
Calcium channel blockers 879 33 335 36 .22
Diabetic agent 287 11 89 9.4 .22
Statins 58 2.2 26 2.8 .33
Clinical history
Myocardial infarction 1376 52 524 56 .07
Chronic obstructive pulmonary disease 213 8.1 84 8.9 .42
Smoking 1013 38 566 60 .01
Heart failure 621 24 206 22 .29
Hypertension 2025 77 696 74 .07
Diabetes: insulin treated 541 21 170 18 .10
Diabetes: non-insulin treated 476 18 177 19 .62
Stroke 204 7.7 76 8.0 .75
Peripheral vascular disease 413 16 154 16 .62
Renal disease 19 0.72 23 2.4 .01
Alcohol use 55 2.1 42 4.4 .01
Atrial fibrillation 142 5.4 42 4.4 .27
Unstable angina 1120 42 366 39 .05
Preoperative pathology
Aortic valve regurgitation 161 6.1 52 5.5 .51
Aortic valve stenosis 48 12 11 1.2 .18
Mitral valve regurgitation 553 21 159 17 .01
Coronary anatomy
Any circumflex system disease 2154 82 799 85 .04
Any left main disease 995 38 376 40 .26
Any LAD system disease 2494 95 897 95 .55
Any RCA system disease 2303 88 838 89 .27
Symptoms
NYHA class
1 336 14 116 13 .33
2 964 39 374 42
3 413 17 135 15
4 773 31 260 29
Canadian angina class
0 54 2.2 25 2.8 .21
1 787 32 280 32
2 1118 45 422 48
3 455 18 135 15
4 71 2.9 23 2.6
Emergency surgery 106 4.0 37 3.9 .90
Cardiogenic shock 15 0.6 5 0.5 .89
Intra-aortic balloon pump 106 4.0 22 2.3 .02
Ventricular function
Abnormal left ventricular function 1264 48 475 50 .19
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lence of unfavorable risk factors in women. A number of
investigations report that gender has no influence on adverse
postoperative outcomes after CABG after adjusting for gen-
der dissimilarities in preoperative risk.3,7,9,14,15 An equiva-
lent number of investigations report an increase in postop-
erative risk for women, despite application of risk-
adjustment strategies.1,2,4,6 Finally, a few investigations
report no difference in operative mortality even with statis-
tically significant gender differences in the preoperative risk
profiles.10-13
Two large investigations report that female gender is an
independent predictor of adverse outcome after CABG
within certain subgroups of patients who underwent
CABG.1,2 Edwards and colleagues1 analyzed the data from
247,760 men and 97,153 women from the Society of Tho-
racic Surgeons National Cardiac Surgery database. Women
were older, presented more commonly for non-elective pro-
cedures, and were reported to have a higher prevalence of
preoperative comorbid conditions, such as diabetes, hyper-
tension, and peripheral vascular disease. Female gender was
an independent predictor of postoperative death within all of
their defined risk groups except within the group with an
operative risk of death greater than 30%. By use of the
Multicenter National Cardiovascular Network database,
Vaccarino and colleagues2 examined the in-hospital mortal-
ity for 36,009 men and 15,178 women who underwent
CABG surgery from 1993 to 1999. They reported that
women aged less than 50 years were at 3 times greater risk
of postoperative mortality compared with men of similar
age groupings. After adjusting for a number of preoperative
comorbid conditions, women aged less than 50 years had
twice the likelihood of postoperative death. Gender differ-
ences for in-hospital mortality were less marked in the older
age subgroups. Our multivariable model for in-hospital
mortality on the data set of 15,587 patients did not find a
significant interaction between age and gender.
Conflicting results among published studies with regard
to the influence of gender on postoperative morbidity and
mortality after CABG are influenced by a number of
factors: dissimilar study designs and data collection
methods, different study sample sizes, and variable ap-
plication of statistical methods to analyze the data sets.
Most of the investigations are nonrandomized observa-
tional studies from large databases, which inherently
entail systematic differences in baseline characteristics
between women and men. Differing approaches to risk
adjustment and the model-selection processes among
these investigations can also lead to variability in the
final model chosen.20
Our investigation of 15,597 patients who underwent
CABG found that a majority of women (74%) are so dis-
tinctly different from men in their preoperative profiles that
they were unable to be matched on propensity scores with
men. Although standard diagnostic procedures for regres-
sion would not reveal an imbalanced representation of the
levels of one covariate within the levels of another, subclas-
sification by propensity makes this imbalance evident. This
demonstrates an advantage of propensity modeling over
regression adjustment in that the investigator may find that
there is effectively no overlap in the distributions of covari-
ates among the groups under investigation. Application of
regression adjustment in this circumstance would result in
problems in drawing valid conclusions from the data with-
out making assumptions that involve extrapolation.19,21 To
demonstrate this concept, we examined the entire data set of
patients and applied multivariable logistic regression
techniques to determine if there were gender differences
in postoperative mortality. Among the variables selected
for the final model, female gender was a significant
predictor of mortality after CABG. In the propensity-
matched patients, postoperative mortality was similar
among the women and men. In fact, after the logistic
model was adjusted by the weights established by the
propensity score, gender did not remain in the model for
mortality.
With the application of propensity score methods, base-
line characteristics can be summarized as a single score that
approximates the background characteristics for the individ-
ual patient.22 Tables 1 and 2 demonstrate that covariates are,
in general, balanced between the women and men, similar to
the balance achieved in a randomized controlled trial. This
allows for a “fair” comparison between women and men
with regard to morbidity and mortality outcomes after
CABG.23
Principal Findings
We report similar mortality among the propensity-matched
women and men undergoing CABG. Despite similar preop-
erative BSA, BMI, red blood cell mass, and rate of reop-
Figure 2. Mirrored histogram displaying distribution of propensity
scores among matched and unmatched women.
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eration for bleeding, women were transfused with red blood
cells at a higher rate compared with propensity-matched
men. Women required longer postoperative ventilatory sup-
port, which, in part, may be related to the amount of
intraoperative narcotics and benzodiazepines administered.
There were also more cardiac arrests, postoperative myo-
cardial infarctions, and intraoperative inotropic agents ad-
ministered in the propensity-matched women compared
with the men. The increase in cardiac events in the propen-
sity-matched women is similar to what has been shown
from other investigations. Brandrup-Wognsen and col-
leagues,4 in a study of 2129 patients undergoing CABG in
western Sweden, reported that women had more indirect
signs of myocardial injury after coronary revascularization.
TABLE 6. Outcome variables between unmatched and matched females
Continuous variables
Unmatched females
(N  2645)
Matched females
(N  945)
Wilcoxon rank
P value
Median (25th, 75th
percentile)
Median (25th, 75th
percentile)
Total minutes myocardial ischemia 61 (42, 80) 63 (44, 81) .08
Total no. of units of RBC in OR and ICU 2.0 (1.0, 4.0) 2.0 (0.0, 3.0) .01
Hours on ventilator in ICU 12 (7.9, 18) 12 (7.5, 18) .15
Hematocrit in ICU 31 (28, 33) 31 (28, 33) .88
Categoric variables
Unmatched females Matched females Chi-square test
P valueN % N %
Coronary endarterectomy 19 0.72 11 1.2 .20
Hospital death 67 2.5 20 2.1 .47
Complications
Neurologic morbidity
Encephalopathy 30 1.1 12 1.3 .74
Focal deficit 42 1.6 12 1.3 .49
Global deficit 14 0.53 7 0.74 .46
Pulmonary morbidity
ARDS 22 0.83 4 0.42 .20
Aspiration pneumonia 8 0.30 1 0.11 .46F
Pneumonia 51 1.9 18 1.9 .96
Pulmonary edema 47 1.8 10 1.1 .13
Tracheostomy 49 1.9 15 1.6 .6
Pulmonary embolus 0 0.0 2 0.21 .07F
Plural effusion 575 22 206 22 .97
Renal morbidity
Renal failure 37 1.4 13 1.4 .96
Anuria 28 1.1 12 1.3 .6
Renal protective dopamine 447 17 167 18 .59
Infection
Sternal wound infection 11 0.42 2 0.21 .53F
Mediastinitis 16 0.60 2 0.21 .18F
Septicemia/sepsis 73 2.8 22 2.3 .48
Endocarditis 2 0.076 0 0.0 .99F
Cardiac morbidity
Low cardiac output 54 2.0 15 1.6 .38
Cardiac arrest 112 4.2 56 5.9 .04
Atrial fibrillation 422 16 137 15 .29
Intra/postoperative IABP 167 6.3 49 5.2 .21
Myocardial infarction 264 10 115 12 .06
Antiarrythmics 363 14 133 14 .79
Inotropic agents 859 33 339 36 .06
Vasopressors 4 0.15 3 0.32 .39F
Multisystem organ failure 27 1.0 7 0.74 .45
Blood product usage
Intraop/postoperative red blood cells 2066 78 655 69 .01
Cryoprecipitate or platelets given 355 13 110 12 .16
Reoperation for bleeding/tamponade 78 3.0 18 1.9 .09
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Their female patients had more frequent use of circula-
tory support with an IABP and greater use of postcar-
diopulmonary bypass inotropics. Christakis and col-
leagues6 found that female gender was an independent
predictor of postoperative mortality and low cardiac out-
put syndrome in their investigation of 7025 patients
undergoing isolated CABG from 1990 to 1994. Women
had a higher occurrence of postoperative myocardial
infarction and need for IABP assistance.6 Woods and
colleagues,3 in their prospective cohort study of 5324
patients who underwent CABG, reported that female
gender was not an independent predictor of mortality;
however, they did find that it was associated with an
increase in low cardiac output conditions after revascu-
larization. Finally, Abramov and colleagues11 reported
that female gender was a weak independent predictor of
perioperative myocardial infarction and IABP usage, but
not for mortality after CABG.
TABLE 7. Comparison of outcome variables matching: Total population
Continuous variables
Females (N  3596) Males (N  12,001) Wilcoxon rank
P valueMedian (25th, 75th percentile) Median (25th, 75th percentile)
Total minutes myocardial ischemia 62 (43, 80) 70 (51, 88) .01
Total no. of units of RBC in OR and ICU 2.0 (1.0, 4.0) 0.0 (0.0, 2.0) .01
Minutes on ventilator in ICU 12 (7.8, 18) 10 (6.7, 16) .01
Hematocrit in ICU 31 (28, 33) 31 (28, 34) .01
Categoric variables
Females Males Chi-square test
P valueN % N %
Coronary endarterectomy 30 0.83 165 1.4 .01
Hospital death 87 2.4 170 1.4 .01
Complications
Neurologic morbidity
Encephalopathy 42 1.2 115 0.96 .27
Focal deficit 54 1.5 114 0.95 .01
Global deficit 21 0.58 27 0.22 .01
Pulmonary morbidity
ARDS 26 0.72 73 0.61 .45
Aspiration pneumonia 9 0.25 48 0.4 .19
Pneumonia 69 1.9 197 1.6 .26
Pulmonary edema 57 1.6 118 0.98 .01
Tracheostomy 64 1.8 133 1.1 .01
Pulmonary embolus 2 0.06 8 0.07 .99F
Plural effusion 782 22 1810 15 .01
Renal morbidity
Renal failure 50 1.4 78 0.65 .01
Anuria 40 1.1 54 0.45 .01
Renal protective dopamine 614 17 2069 17 .82
Infection
Sternal wound infection 13 0.36 32 0.27 .35
Mediastinitis 18 0.5 44 0.37 .26
Septicemia/sepsis 95 2.6 198 1.7 .01
Endocarditis 2 0.06 2 0.02 .23F
Cardiac morbidity
Low cardiac output 69 1.9 105 0.87 .01
Cardiac arrest 168 4.7 406 3.4 .01
Atrial fibrillation 559 16 1537 13 .01
Intra/postoperative IABP 381 11 1070 8.9 .01
Myocardial infarction 216 6 576 4.8 .01
Antiarrythmics 497 14 1693 14 .66
Inotropic agents 1202 33 3138 26 .01
Vasopressors 7 0.19 30 0.25 .55
Multisystem organ failure 34 0.95 54 0.45 .01
Blood product usage
Intra/postoperative red blood cells 2725 76 5425 45 .01
Cryoprecipitate or platelets given 466 13 1367 11 .01
Reoperation for bleeding/tamponade 97 2.7 284 2.4 .26
Surgery for Acquired Cardiovascular Disease Koch et al
2040 The Journal of Thoracic and Cardiovascular Surgery ● December 2003
A
CD
Outcomes in Unmatched Women
Recognizing that a majority of women were unable to be
matched on propensity scores with men, we further exam-
ined this group of unmatched women and compared them
with the propensity-matched women. The unmatched
women had a distinctly different preoperative profile com-
pared with the matched women. They had a large number of
variables that typify the preoperative profile of the female
patient undergoing CABG: lower hematocrits and red blood
cell mass, shorter stature, lower bilirubin, increased triglyc-
erides, higher high-density lipoprotein cholesterol, and less
prevalence of smoking cigarettes and drinking alcohol.17
Despite these differences in profiles, the unadjusted postop-
erative mortality and morbidity outcomes were similar.
Outcomes in Propensity-Matched Coronary
Reoperations
Patients undergoing coronary reoperations represent a sub-
group of patients who are reported to be at increased risk of
postoperative morbidity and mortality.24-26 The preopera-
tive risk profile for patients undergoing coronary reopera-
tions has been typified by patients who are more frequently
male, with more left ventricular dysfunction, with a greater
Canadian Cardiovascular Society symptom class, and who
present more commonly for urgent surgery compared with
patients undergoing primary CABG.26 In particular, female
gender has been reported to be an independent predictor of
increased postoperative mortality after reoperative CABG.
Aidala and colleagues,24 in a small retrospective study,
reported an 11.4% mortality for patients undergoing reop-
erative CABG versus a 3.2% mortality for patients under-
going primary operations. They reported that female gender
was a risk factor for postoperative mortality. Weintraub and
colleagues,25 from their database of 2030 coronary reopera-
tions, reported that female gender was correlated with in-
hospital death both in the univariable and multivariable
analyses. Although Yau and colleagues26 did not report
female gender to be an independent predictor of postoper-
ative mortality in 1230 patients undergoing reoperative
CABG, they reported that it was an independent predictor of
postoperative low cardiac output syndrome. We report that
among the propensity-matched pairs undergoing coronary
reoperations, women have a lower postoperative mortality
compared with similarly matched men. Postoperative mor-
bidity was similar among well-matched women and men
undergoing coronary reoperations.
Limitations
One of the limitations of this observational investigation
was that there may have been unmeasured confounding
variables that impacted the propensity matching of women
and men who underwent CABG. In addition, the amount of
anesthetic medications administered intraoperatively was
not a measured variable. The omission of this information
may have impacted the findings of gender differences in the
duration of postoperative ventilatory support observed in
this investigation. Furthermore, we did not record data on
all “processes of care” in the operating room. For example,
complications from repeat sternotomy, such as graft exci-
sion or right ventricular damage, were not recorded vari-
ables. This lack of information may have influenced the
observed gender differences in postoperative mortality for
the propensity-matched patients who underwent reoperative
CABG.
Conclusions
Dissimilarities in profiles may contribute to the debate about
gender differences in outcome after coronary revasculariza-
tion. In well-matched patients, female gender was not a risk
factor for in-hospital mortality and had minimal impact on
postoperative morbidity.
TABLE 8. Factors associated with hospital death (parsimonious model)
Probability of
hospital death Factor Estimate  SE P
Bagging
(%)*
Intercept 2.62 0.61 .001 —
Higher Female† 0.30 0.15 .042 6
Higher Age2 0.75 0.14 .001 100
Lower Preoperative albumin 0.94 0.13 .001 74
Higher History of peripheral vascular disease 0.69 0.15 .001 66
Lower Hyperlipidemia 0.55 0.16 .001 66
Higher History of heart failure 0.57 0.15 .001 59
Lower Ramus stenosis 0.011 0.0037 .0033 82
Higher Previous bypass graft disease 0.83 0.15 .001 74
Higher Major blood transfusion 3.28 0.18 .001 100
Higher Abnormal left ventricular function 0.40 0.15 .0083 77
*Frequency of occurrence in bagging samples, indicating the reliability of obtaining P  .05.
†When propensity score was added to the covariates, gender was no longer significant with a P value of .17.
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